HYMAN PHELPS & MCNAMARA

Lobbying Income

$440K

Filings

Unique Clients

Active Period

1999–2013

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2013	—	2	1
2006	$0	6	4
2005	$60,000	7	5
2004	$120,000	8	4
2003	$140,000	11	6
2002	$40,000	4	2
2001	$40,000	4	2
2000	$0	6	2
1999	$40,000	6	3

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
EPHEDRA COMMITTEE OF AMERICAN HERBAL PRODUCTS ASSN	$120,000	9	1999–2003
SOLVAY PHARMACEUTICALS	$120,000	6	2003–2006
CELLTECH GROUP PLC	$80,000	8	2003–2006
JOHNSON & JOHNSON	$80,000	6	2003–2006
CEPHALON	$40,000	5	2003–2006
DIETARY SUPPLEMENT SAFETY & SCIENCE COALITION	$0	2	1999
HOFFMANN-LA ROCHE	$0	11	1999–2005
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA	—	2	2013
MEDEVA PHARMACEUTICALS INC	$0	5	2000–2001

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	30
SENATE	30
Justice, Dept of (DOJ)	2
Drug Enforcement Administration (DEA)	1
Food & Drug Administration (FDA)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Alcohol and Drug Abuse	Alcohol and Drug Abuse	22
Food Industry (safety, labeling, etc.)	Food Industry (safety, labeling, etc.)	11
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	5
Law Enforcement/Crime/Criminal Justice	Law Enforcement/Crime/Criminal Justice	5
Health Issues	Health Issues	3

HYMAN PHELPS & MCNAMARA — Lobbying Disclosure | Poliscope